Jemincare is born for “industry to serves the country, benefits people's livelihood”.
The history of Jemincare is an honor in the development of the national pharmaceutical industry.
For 20 years, Jemincare is practicing group mission and making innovations to promote the development of China’s pharmaceutical industry.
- 1999Yichun Xiu Jiang pharmaceutical plants changed its name into”Jiangxi Jemincare Pharmaceutical Co., Ltd”
- 2000Establishment of Jiangxi Jemincare Group Co., Ltd.
- 2004Mergering Jiangxi Jinshui Bao Pharmaceutical Co., Ltd
- 2006Wuxi Shan He pharmaceutical industry joined Jemincare
- 2010Jemincare three QC achievements won the National Honor Award
- 2012 Signing a contract with Zhejiang Kang Lai Te cooperation and entering cancer treatment field
- 2013Jemincare Wuxi Shan He pharmaceutical has been awarded the title of “post doctoral workstation”
Jemincare Yichun pharmaceutical testing center won the National Laboratory(CNAS)certificate.
- 2014Holding Changzhou Jinyuan pharmaceutical industry and having leading research and development platform of lipidosome.
- 2015Kanglaite Injection got FDA certification in the US and entered Phase Ⅲ clinical trial of pancreatic cancer .
Mergering Jiangxi National Medicine Co., Ltd."No. 1 Care Worker" platform went online and entered the field of internet medical care.
- 2016 Jemincare pharmaceutical Co., Ltd. was recognized as “National Intellectual Property Demonstration Enterprise”.
"Jemincare" and "Jinshui Bao" were awarded the well-known trademarks in China
Jemincare wholly-owned acquisited Jiangxi Jiuhua Pharmaceutical Co., Ltd.
Jemincare was awarded as the sixth in “ China Pharmaceutical Industry Top 100 List”.
The tenth in the "2016 China Pharmaceutical Industry Top 100".
Jiangxi Jemincare financial information and services, Ltd. was established, and entered the financial services sector.
Jiangxi Jemincare Insurance Brokers LLC obtains insurance brokerage license
Jemincare Wuxi Shan He pharmaceutical was selected as the national intellectual property advantage company.
Jemincare global scientific headquarters is stationed in Shanghai
Jemincare was reelected as the sixth in the "2017 Chinese Pharmaceutical Industry Top 100"
The tenth in the “2017 China Pharmaceutical Industry Top 100 List”
"The most powerful enterprise of China pharmaceutical industry in 2017"
The construction of Jemincare Yaohu New Headquarters and New Drug Industrialization Base was begun
The first phase of the construction of Jimin Trust Biomedical Industrial Park was begun.